OIS XIV

Meet us at OIS XIV

Learn more about our solutions for Pharma: RWE, accelerating Clinical Trials and Data Analysis!

RetinAI Discovery is set to revolutionize the management and research of retinal diseases with its advanced AI-driven analytics platform. Leveraging cutting-edge technology, Discovery offers a comprehensive suite of tools for the detailed analysis of retinal imaging, enabling the early detection, accurate diagnosis, and effective monitoring of conditions like AMD, GA, DR, DME, and more.

Join us at the OIS Retina Innovation Summit XIV 2024 to network with our team and see the full capabilities of the Discovery platform and how it's facilitating breakthroughs in personalized patient care and advanced retinal research.

How Life Sciences Companies use our RWE insights?

‍

Clinical Development

Enhance your clinical trials by pinpointing unmet needs for better research design, refining inclusion and exclusion criteria, and selecting the right patients based on biomarkers of interest.
‍

Health Economic & Outcomes Research

Demonstrate the value of treatments to payers, compare study data with actual real-world outcomes, and support value-based pricing strategies.

Commercialization

Enhance your product positioning and messaging, gain deeper insights into market knowledge, treatment trends, and factors influencing treatment decisions.

‍
Learn more visiting our Real-World Evidence product page

‍